What volume of nystatin oral suspension (in milliliters) should be used for swish‑and‑swallow therapy in oral oropharyngeal candidiasis?

Nystatin Swish-and-Swallow Dosing for Oral Candidiasis

For mild oropharyngeal candidiasis, use 4–6 mL of nystatin suspension (100,000 units/mL) four times daily for 7–14 days, swishing thoroughly before swallowing. 1

Standard Dosing Regimen

• Volume per dose: 4–6 mL (delivering 400,000–600,000 units per dose) 1, 2
• Frequency: Four times daily 1, 2
• Duration: 7–14 days, continuing for at least 48 hours after symptoms resolve 1, 2
• Administration technique: Swish the suspension throughout the mouth for at least 2 minutes to ensure contact with all affected areas, then swallow rather than spit out to treat potential esophageal involvement 2, 3

Critical Limitations of Nystatin

Nystatin has markedly inferior efficacy compared to systemic fluconazole and should be reserved only for mild disease in immunocompetent patients. 2, 4, 5

• Clinical cure rates with nystatin range from only 32–54%, compared to 87–100% with fluconazole 2, 4, 5
• In HIV-infected patients, nystatin achieved only 52% cure versus 87% with fluconazole, with significantly higher relapse rates (44% vs 18%) 4
• In infants, nystatin cured only 32% versus 100% with fluconazole 5

When to Use Systemic Fluconazole Instead

Switch to oral fluconazole 100–200 mg once daily for 7–14 days in the following situations: 1, 2

• Moderate-to-severe disease (extensive lesions, posterior pharyngeal involvement) 1, 2
• Immunocompromised patients (HIV, neutropenia, transplant recipients) 2, 3
• Suspected esophageal involvement (even without dysphagia, as topical agents cannot penetrate esophageal tissue) 2, 3
• Treatment failure after 7–14 days of nystatin 2, 3

Alternative Topical Formulations

If systemic therapy is contraindicated (e.g., pregnancy, significant drug interactions):

• Clotrimazole troches: 10 mg dissolved in mouth five times daily for 7–14 days—more convenient than nystatin but still less effective than fluconazole 1, 2
• Miconazole mucoadhesive buccal tablet: 50 mg once daily for 7–14 days—the most convenient topical option 2, 3
• Nystatin pastilles: 1–2 pastilles (200,000 units each) four times daily for 7–14 days as an alternative to suspension 1, 2

Common Pitfalls to Avoid

• Do not use nystatin for moderate-to-severe disease or immunocompromised patients—systemic fluconazole is mandatory because topical agents cannot address esophageal extension 2, 3
• Do not repeat nystatin after early recurrence—this indicates treatment failure and requires escalation to systemic therapy 2
• Do not spit out the suspension—swallowing is essential to treat potential esophageal involvement 2, 3
• Do not use inadequate contact time—swishing for less than 2 minutes reduces efficacy 2, 3

Special Populations

• Pregnancy: Nystatin is preferred over fluconazole due to teratogenic risk; use standard 4–6 mL four times daily dosing 2
• Denture-related candidiasis: Concurrent denture disinfection and overnight removal are mandatory adjuncts to any antifungal therapy 1, 2
• HIV-infected patients: Use the same nystatin dosing if topical therapy is chosen, but initiating antiretroviral therapy has greater impact on reducing recurrence than antifungal choice 2, 3

Management of Treatment Failure

If symptoms persist after 7–14 days of nystatin:

• First-line alternative: Itraconazole solution 200 mg once daily for up to 28 days (effective in approximately two-thirds of fluconazole-refractory cases) 2, 3
• Second-line options: Posaconazole suspension 400 mg twice daily for 3 days then 400 mg daily, voriconazole 200 mg twice daily, or amphotericin B oral suspension 100 mg/mL four times daily 2, 3